John M. Evans - 31 Oct 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: CEO, Director
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol: BEAM
Transactions as of: 31 Oct 2022
Net transactions value: -$2,316,428
Form type: 4
Filing time: 02 Nov 2022, 16:30:23 UTC
Previous filing: 29 Jul 2022
Next filing: 31 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAM	Common Stock	Sale	$339,944	-7,567	-0.7%	$44.92	1,080,953	31 Oct 2022	Direct	F1, F2
transaction	BEAM	Common Stock	Sale	$358,819	-7,768	-0.72%	$46.19	1,073,185	31 Oct 2022	Direct	F1, F3
transaction	BEAM	Common Stock	Sale	$551,137	-11,756	-1.1%	$46.88	1,061,429	31 Oct 2022	Direct	F1, F4
transaction	BEAM	Common Stock	Sale	$139,325	-2,909	-0.27%	$47.89	1,058,520	31 Oct 2022	Direct	F1, F5
transaction	BEAM	Common Stock	Sale	$224,993	-5,008	-4.1%	$44.93	117,992	31 Oct 2022	By John M. Evans, III 2018 Irrevocable Trust	F1, F6
transaction	BEAM	Common Stock	Sale	$211,034	-4,569	-3.9%	$46.19	113,423	31 Oct 2022	By John M. Evans, III 2018 Irrevocable Trust	F1, F7
transaction	BEAM	Common Stock	Sale	$386,339	-8,235	-7.3%	$46.91	105,188	31 Oct 2022	By John M. Evans, III 2018 Irrevocable Trust	F1, F8
transaction	BEAM	Common Stock	Sale	$104,836	-2,188	-2.1%	$47.91	103,000	31 Oct 2022	By John M. Evans, III 2018 Irrevocable Trust	F1, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $44.48 to $45.445, inclusive.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $45.57 to $46.56, inclusive.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.57 to $47.52, inclusive.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.68 to $48.17, inclusive.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $44.48 to $45.445, inclusive.
F7	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $45.57 to $46.56, inclusive.
F8	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.57 to $47.555, inclusive.
F9	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.57 to $48.40, inclusive.